The integration of Fusion with FactSet was prompted by J.P. Morgan's institutional clients, who wanted to receive J.P. Morgan data using modern technology, according to Jason Mirsky, J.P. Morgan ...

Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter company to discontinue development of the program. Back in 2019, the companies ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...